The increasing incidence of asthma in the general population results in increased numbers of patients with poorly controlled asthma presenting for surgery and to the intensive care unit. Such patients are at increased risk for perioperative bronchospasm, rapid onset of which implicates airway smooth muscle in its etiology. The primary therapy of acute bronchospasm includes agents (i.e., beta-adrenergic agonists) that increase levels in airway smooth muscle cells of cAMP, a second messenger that plays a pivotal role in airway smooth muscle tone. This pathway is down regulated in patients with asthma, but the mechanism by which this occurs is unknown. In the asthmatic lung chronic activation of irritant refleses releases acetylcholine from parasympathetic nerves which, along with inflammatory mediators, chronically activate the Gq/PKC sinalling pathway. Preliminary data suggest that this chronic Gq/PKC activation cross-regulates and down regulates adenylyl cyclase enzymes responsible for the synthesis of cAMP in response to the therapeutic agents used to treat asthma. The overall plan of this proposal is to understand the mechanisms by which chronic activation of the Gq/PKC signalling pathway in asthma down regulates the functiona and expression of adenylyl cyclases in airway smooth muscle. The time course, dose response and revesibility of chronic activation of Gq/PKC on decreased adenylyl cyclase function and protein expression will be determined. The isoforms of adenylyl cyclase expressed in airway smooth muscle will be identified by northern blot analysis of poly A+ RNA. The mechanism of the down regulation in response to chronic Gq/PKC activation will be characterized at the protein level using 3H-forskolin binding and at the mRNA level using northern blot, ribonuclease protection and competitive PCR approaches.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL058519-03
Application #
2901315
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1998-04-01
Project End
2003-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Osawa, Yoko; Yim, Peter D; Xu, Dingbang et al. (2007) Raf-1 kinase mediates adenylyl cyclase sensitization by TNF-alpha in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292:L1414-21
Osawa, Yoko; Xu, Dingbang; Sternberg, David et al. (2006) Functional expression of the GABAB receptor in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 291:L923-31
Jooste, Edmund; Klafter, Farrah; Hirshman, Carol A et al. (2003) A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 98:906-11
Hirshman, C A; Zhu, D; Panettieri, R A et al. (2001) Actin depolymerization via the beta-adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway. Am J Physiol Cell Physiol 281:C1468-76
Fehr, J J; Hirshman, C A; Emala, C W (2000) Cellular signaling by the potent bronchoconstrictor endothelin-1 in airway smooth muscle. Crit Care Med 28:1884-8
Emala, C W; Liu, F; Hirshman, C A (1999) Gialpha but not gqalpha is linked to activation of p21(ras) in human airway smooth muscle cells. Am J Physiol 276:L564-70
Hotta, K; Emala, C W; Hirshman, C A (1999) TNF-alpha upregulates Gialpha and Gqalpha protein expression and function in human airway smooth muscle cells. Am J Physiol 276:L405-11
Hirshman, C A; Togashi, H; Shao, D et al. (1998) Galphai-2 is required for carbachol-induced stress fiber formation in human airway smooth muscle cells. Am J Physiol 275:L911-6